LUNG CANCER SURPASSED BREAST
CANCER AS THE #1 KILLER OF
WOMEN IN 1987.

 

Endocyte reports positive interim results from Phase II lung cancer trial

March 31st, 2009

cidcap-endocyteEndocyte, a biotechnology company, has announced positive interim results from an ongoing Phase II clinical study of EC145 in patients with advanced non-small cell lung cancer. EC145 to treat chemotherapy-resistant non-small cell lung cancer patients

 

Posted in Non-Small-Cell, Research, Treatment by Debi

Trackback

 
«
»

Leave a Reply